Primary hyperparathyroidism: Short-term changes in bone remodeling and bone mineral density following parathyroidectomy

Bone

Volumn 25, Issue 2, 1999, Pages 237-244

  Christiansen, P ^a   Steiniche, T ^b   Brixen, K ^a   Hessov, I ^a   Melsen, F ^b   Heickendorff, L ^a   Mosekilde, Le ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University Institute of Pathology Arhus   (Denmark)

Author keywords

Bone density; Bone histomorphometry; Bone mineral density; Bone remodeling; Follow up study; Hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BONE REMODELING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HYDROXYPROLINE URINE LEVEL; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM;

AGED; BIOLOGICAL MARKERS; BIOPSY; BONE AND BONES; BONE DENSITY; BONE REGENERATION; CALCIUM; COHORT STUDIES; COLLAGEN; COLLAGEN TYPE I; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM; ILIUM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; PEPTIDES; REFERENCE VALUES;

EID: 0033052927     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00150-7     Document Type: Article

References (38)

1. Abugassa S., Nordenstrom J., Eriksson S., Mollerstrom G., Alveryd A. Skeletal remineralization after surgery for primary and secondary hyperparathyroidism. Surgery. 107:1990;128-133.
2. Alhava E.M., Karjalainen P., Paakkonen M. Bone mineral density and surgical treatment of primary hyperparathyroidism. Acta Chir Scand. 154:1988;345-347.
3. Bilezikian J.P., Silverberg S.J., Shane E., Parisien M., Dempster D.W. Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Miner Res. 6:(Suppl. 2):1991;S85-S89.
4. Brixen K., Nielsen H.K., Eriksen E.F., Charles P., Mosekilde L. Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate Comparison to serum total alkaline phosphatase and serum bone Gla-protein [see comments] . Calcif Tissue Int. 44:1989;93-98.
5. Brockstedt H., Christiansen P., Mosekilde L., Melsen F. Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone. 16:1995;109-117.
6. Christiansen P., Steiniche T., Brixen K., et al. Primary hyperparathyroidism Biochemical markers and bone mineral density at multiple skeletal sites in Danish patients . Bone. 21:1997;93-99.
7. Christiansen P., Steiniche T., Brockstedt H., Mosekilde L., Hessov I., Melsen F. Primary hyperparathyroidism Iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods . Bone. 14:1993;755-762.
8. Christiansen P., Steiniche T., Mosekilde L., Hessov I., Melsen F. Primary hyperparathyroidism Changes in trabecular bone remodeling following surgical treatment evaluated by histomorphometric methods . Bone. 11:1990;75-79.
9. Christiansen P., Steiniche T., Vesterby A., Mosekilde L., Hessov I., Melsen F. Primary hyperparathyroidism Iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods . Bone. 13:1992;41-49.
10. Clements M.R., Davies M., Fraser D.R., Lumb G.A., Mawer E.B., Adams P.H. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci. 73:1987;659-664.
11. Elvius M., Lagrelius A., Nygren A., Alveryd A., Christensson T.A., Nordenström J. Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. Eur J Surg. 161:1995;863-869.
12. Eriksen E.F., Mosekilde L., Melsen F. Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone. 7:1986;213-221.
13. Garton M., Martin J., Stewart A., et al. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism. Clin Endocrinol (Oxf). 42:1995;493-500.
14. Guo C.Y., Thomas W.E., al Dehaimi A.W., Assiri A.M., Eastell R. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 81:1996;3487-3491.
15. Hanson D.A., Weis M.A., Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption Quantitation of type I collagen cross-linked N-telopeptides in urine . J Bone Miner Res. 7:1992;1251-1258.
16. Hesp R., Tellez M., Davidson L., Elton A., Reeve J. Trabecular and cortical bone in the radii of women with parathyroid adenomata A greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy . Bone Miner. 2:1987;301-310.
17. 125I-labeled tracer. Clin Chem. 39:1993;529-533.
18. Hoshino H., Kushida K., Takahashi M., et al. Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism. Miner Electrolyte Metab. 23:1997;93-99.
19. Keiding R., Hörder M., Gerhardt W., et al. Recommended methods for the determination of four enzymes in the blood. Scand J Clin Lab Invest. 33:1974;291-306.
20. Martin P., Bergmann P., Gillet C., Fuss M., Corvilain J., Van Geertruyden J. Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Arch Intern Med. 150:1990;1495-1497.
21. Martin P., Bergmann P., Gillet C., et al. Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med. 146:1986;689-691.
22. McDermott M.T., Perloff J.J., Kidd G.S. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res. 9:1994;509-514.
23. Melsen F., Mosekilde L. The role of bone biopsy in the diagnosis of metabolic bone disease. Orthop Clin N Am. 12:1981;571-602.
24. Minisola S., Romagnoli E., Scarnecchia L., et al. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism Studies in basal conditions and after parathyroid surgery . Eur J Endocrinol. 130:1994;587-591.
25. Mole P.A., Walkinshaw M.H., Gunn A., Paterson C.R. Bone mineral content in patients with primary hyperparathyroidism A comparison of conservative management with surgical treatment . Br J Surg. 79:1992;263-265.
26. Mosekilde L., Charles P., Lindegreen P. Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Bone Miner. 5:1989;279-290.
27. Parisien M., Silverberg S.J., Shane E., et al. The histomorphometry of bone in primary hyperparathyroidism Preservation of cancellous bone structure . J Clin Endocrinol Metab. 70:1990;930-938.
28. Pfeilschifter J., Siegrist E., Wuster C., Blind E., Ziegler R. Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. Acta Endocrinol Copenh. 127:1992;319-323.
29. Price P.A., Nishimoto S.K. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA. 77:1980;2234-2238.
30. Risteli J., Elomaa I., Niemi S., Novamo A., Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen A new serum marker of bone collagen degradation . Clin Chem. 39:1993;635-640.
31. Rosalki S.B., Foo A.Y. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzyme in plasma. Clin Chem. 30:1984;1182-1186.
32. Scalzetti E.M., Levinsohn E.M., Numann P., Bassano D.A. Vertebral mineralization after parathyroidectomy Measurement by quantitative CT . Am J Roentgenol. 151:1988;533-535.
33. Seeman E., Wahner H.W., Offord K.P., Kumar R., Johnson W.J., Riggs B.L. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest. 69:1982;1302-1309.
34. Seibel M.J., Gartenberg F., Silverberg S.J., Ratcliffe A., Robins S.P., Bilezikian J.P. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab. 74:1992;481-486.
35. Silverberg S.J., Gartenberg F., Jacobs T.P., et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism [see comments]. J Clin Endocrinol Metab. 80:1995;729-734.
36. Silverberg S.J., Shane E., De La Cruz L., et al. Skeletal disease in primary hyperparathyroidism [see comments]. J Bone Miner Res. 4:1989;283-291.
37. Tanaka Y., Funahashi H., Imai T., Tominaga Y., Takagi H. Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism. Semin Surg Oncol. 13:1997;125-133.
38. Wishart J., Horowitz M., Need A., Nordin B.E. Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism. Arch Intern Med. 150:1990;1329-1331.